PetMed Express Files 8-K on Financials

Ticker: PETS · Form: 8-K · Filed: Nov 6, 2024 · CIK: 1040130

Petmed Express Inc 8-K Filing Summary
FieldDetail
CompanyPetmed Express Inc (PETS)
Form Type8-K
Filed DateNov 6, 2024
Risk Levellow
Pages2
Reading Time3 min
Sentimentneutral

Sentiment: neutral

Topics: financial-reporting, 8-k

Related Tickers: PETS

TL;DR

PETS filed an 8-K, expect financial updates soon.

AI Summary

PetMed Express, Inc. filed an 8-K on November 6, 2024, reporting on its Results of Operations and Financial Condition, and filing Financial Statements and Exhibits. The filing does not contain specific financial figures or operational details within the provided text, but indicates a formal reporting event.

Why It Matters

This filing is a standard regulatory disclosure for PetMed Express, Inc., providing investors and the public with updates on the company's financial condition and operations.

Risk Assessment

Risk Level: low — This is a routine 8-K filing for financial reporting and does not indicate any immediate adverse events.

Key Players & Entities

  • PETMED EXPRESS INC (company) — Registrant
  • Florida (location) — State of incorporation
  • 420 SOUTH CONGRESS AVENUE (address) — Principal executive offices
  • Delray Beach (location) — City of principal executive offices

FAQ

What specific financial information is being reported in this 8-K?

The provided text indicates the 8-K is for 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits', but does not detail the specific figures within this excerpt.

When was this 8-K filing submitted?

The filing was submitted on November 6, 2024.

What is the principal business address of PetMed Express, Inc.?

The principal executive offices are located at 420 South Congress Avenue, Delray Beach, Florida 33445.

What is the SIC code for PetMed Express, Inc.?

The Standard Industrial Classification code is 5912, which corresponds to RETAIL-DRUG STORES AND PROPRIETARY STORES.

Is this filing related to a specific event or ongoing reporting?

This is a 'Current Report' filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, indicating it is for reporting current information, specifically financial condition and operations.

Filing Stats: 632 words · 3 min read · ~2 pages · Grade level 10.5 · Accepted 2024-11-06 17:02:19

Filing Documents

02 Results of Operations and Financial Condition

Item 2.02 Results of Operations and Financial Condition. On November 6, 2024, PetMed Express, Inc. (the "Company") issued a press release announcing its September 30, 2024 second quarter of fiscal year 2025 financial results and other financial information, and that management would review these results in a conference call at 4:30 pm Eastern time on November 6, 2024. A copy of the press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. The information in this Item 2.02 and the information contained in Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended ("Exchange Act"), or otherwise subject to the liabilities of that section, and shall not be deemed incorporated by reference in any Company filing under the Securities Act of 1933, as amended ("Securities Act"), or the Exchange Act, whether made before or after the date hereof and regardless of any general incorporation language in such filings, except as shall be expressly set forth by specific reference in such filing. The Company is making reference to non-GAAP financial information in both the press release and the conference call. A reconciliation of these non-GAAP financial measures to the nearest comparable GAAP financial measures is contained in the attached press release.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits. 99.1 – Press release dated November 6, 2024. 104 – Cover Page Interactive Data File (formatted as Inline XBRL). EXHIBIT INDEX Exhibit No. Description 99.1 Press release dated November 6, 2024 104 Cover Page Interactive Data File (formatted as Inline XBRL) 2

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: November 6, 2024 PETMED EXPRESS, INC. By: /s/ Sandra Y. Campos Name: Sandra Y. Campos Title: Chief Executive Officer and President 3

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.